Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) EPS (Weighted Average and Diluted): 2020-2021

Historic EPS (Weighted Average and Diluted) for Black Diamond Therapeutics (BDTX) over the last 2 years, with Dec 2021 value amounting to -$3.47.

  • Black Diamond Therapeutics' EPS (Weighted Average and Diluted) fell 12.70% to -$0.71 in Q4 2021 from the same period last year, while for Dec 2021 it was -$3.15, marking a year-over-year decrease of 44.27%. This contributed to the annual value of -$3.47 for FY2021, which is 69.27% down from last year.
  • As of FY2021, Black Diamond Therapeutics' EPS (Weighted Average and Diluted) stood at -$3.47, which was down 69.27% from -$2.05 recorded in FY2020.
  • In the past 5 years, Black Diamond Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of -$2.05 in FY2020 and a low of -$3.47 during FY2021.
  • Over the past 2 years, Black Diamond Therapeutics' median EPS (Weighted Average and Diluted) value was -$2.76 (recorded in 2020), while the average stood at -$2.76.
  • Data for Black Diamond Therapeutics' EPS (Weighted Average and Diluted) shows a maximum YoY plummeted of 69.27% (in 2021) over the last 5 years.
  • Over the past 2 years, Black Diamond Therapeutics' EPS (Weighted Average and Diluted) (Yearly) stood at -$2.05 in 2020, then crashed by 69.27% to -$3.47 in 2021.